Fortrea Holdings Inc. reported second quarter 2026 financial results, posting revenues of $678.2 million and adjusted EBITDA of $58.7 million. The company raised its full-year 2026 revenue guidance to a range of $2,620 million to $2,690 million and adjusted EBITDA guidance to $205 million to $220 million. Concurrently, the Board appointed David Smith as Interim Chief Financial Officer following the placement of Jason Knoblauch on paid leave due to pending litigation involving restrictive covenants from his prior employer. Fortrea operates in the clinical research organization industry.
